Adaptation of the Start-Growth-Time Method for High-Throughput Biofilm Quantification.

Frontiers in Microbiology
Lara ThiemeMathias W Pletz

Abstract

Colony forming unit (CFU) determination by agar plating is still regarded as the gold standard for biofilm quantification despite being time- and resource-consuming. Here, we propose an adaption of the high-throughput Start-Growth-Time (SGT) method from planktonic to biofilm analysis, which indirectly quantifies CFU/mL numbers by evaluating regrowth curves of detached biofilms. For validation, the effect of dalbavancin, rifampicin and gentamicin against mature biofilms of Staphylococcus aureus and Enterococcus faecium was measured by accessing different features of the viability status of the cell, i.e., the cultivability (conventional agar plating), growth behavior (SGT) and metabolic activity (resazurin assay). SGT correlated well with the resazurin assay for all tested antibiotics, but only for gentamicin and rifampicin with conventional agar plating. Dalbavancin treatment-derived growth curves showed a compared to untreated controls significantly slower increase with reduced cell doubling times and reduced metabolic rate, but no change in CFU numbers was observed by conventional agar plating. Here, unspecific binding of dalbavancin to the biofilm interfered with the SGT methodology since the renewed release of dalbavancin d...Continue Reading

References

Aug 28, 2002·International Journal of Medical Microbiology : IJMM·Philip S Stewart
Jan 9, 2003·Journal of Clinical Microbiology·Longzhu CuiKeiichi Hiramatsu
Mar 5, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G A Pankey, L D Sabath
Jan 27, 2006·Antimicrobial Agents and Chemotherapy·Longzhu CuiKeiichi Hiramatsu
Feb 9, 2006·The Journal of Antimicrobial Chemotherapy·Jonathan A T SandoeMark H Wilcox
Jan 7, 2009·Antimicrobial Agents and Chemotherapy·Douglas J BiedenbachRonald N Jones
May 12, 2009·Journal of Microbiological Methods·Malena E SandbergAdyary Fallarero
Jun 10, 2010·Annual Review of Microbiology·Kim Lewis
Apr 4, 2012·FEMS Immunology and Medical Microbiology·Luanne Hall-StoodleyThomas Bjarnsholt
Dec 25, 2013·Journal of Microbiological Methods·Freija Van den DriesscheTom Coenye
Apr 29, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M D MaciàA Oliver
May 14, 2014·Methods in Molecular Biology·Ronen HazanLaurence G Rahme
Apr 16, 2016·Nature Reviews. Microbiology·Asher BraunerNathalie Q Balaban
Aug 12, 2016·Nature Reviews. Microbiology·Hans-Curt FlemmingStaffan Kjelleberg
Nov 22, 2016·Critical Reviews in Microbiology·Joana AzeredoClaus Sternberg
Dec 3, 2017·Diagnostic Microbiology and Infectious Disease·Katharina NeudorferRobin Patel
Jan 18, 2018·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T CoenyeT Bjarnsholt
Apr 6, 2018·Clinical Microbiology Reviews·Maria MaganaGeorge P Tegos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

CRISPRi Screens for Antibiotics

The CRISPR-Cas system is a gene editing technique that can be used for high-throughput genome-wide screens to identify modes of actions of novel antibiotics. Here is the latest research.